Literature DB >> 11094212

Apparent heparin resistance from elevated factor VIII during pregnancy.

R A Raschke1, J R Guidry, M R Foley.   

Abstract

BACKGROUND: Heparin resistance is the need for more than 35,000 units of heparin per 24 hours to achieve therapeutic activated partial thromboplastin time (APTT) values. Elevated factor VIII can cause apparent heparin resistance by suppressing the APTT result without inhibiting the antithrombotic effect of heparin. CASE: A 41-year-old gravida 2 para 0 presented at 25 weeks of a twin gestation with a deep venous thrombosis that required unusually high doses of heparin, resulting in hematuria. Apparent heparin resistance caused by elevated factor VIII was diagnosed, and the heparin dose was appropriately decreased with anti-Xa heparin monitoring. The deep venous thrombosis and hematuria resolved.
CONCLUSION: Factor VIII rises significantly during pregnancy, and can cause apparent heparin resistance. When this occurs, anti-Xa heparin levels are superior to APTT for monitoring heparin therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11094212     DOI: 10.1016/s0029-7844(00)01053-x

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Apparent heparin resistance in a patient with infective endocarditis secondary to elevated factor VIII levels.

Authors:  Ramya Thota; Apar Kishor Ganti; Shanmuga Subbiah
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

Review 2.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Using anti-Xa level for adjusting intravenous unfractionated heparin infusion in peripartum thromboembolic disease.

Authors:  Enrica Tse; Rshmi Khurana; Gwen Clarke; Winnie Sia
Journal:  Obstet Med       Date:  2018-05-17

Review 4.  Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.

Authors:  Maureen A Smythe; Jennifer Priziola; Paul P Dobesh; Diane Wirth; Adam Cuker; Ann K Wittkowsky
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

5.  To be or not to be a case of heparin resistance.

Authors:  Jibran Durrani; Faizan Malik; Naveed Ali; Syed Imran Mustafa Jafri
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.